Bioethics

Bioethics Shares Outstanding

The The number of shares of Bioethics (BOTH) as of Nov 20, 2026 is 3.60 M. In the previous year, The number of shares was 3.60 M — a change of 0.00% (lower).

Shares Outstanding

3.60 M

YoY

0.00%

Last updated:

In 2025, Bioethics had 3.60 M outstanding stocks, a 0.00% change from the 3.60 M stocks in the previous year.

The Bioethics Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2018
3.60 M USD
Jan 1, 2019
3.60 M USD
Jan 1, 2020
3.60 M USD
Jan 1, 2021
3.60 M USD
Jan 1, 2022
3.60 M USD
Jan 1, 2023
3.60 M USD
Jan 1, 2024
3.60 M USD
Jan 1, 2025
3.60 M USD
The Bioethics Shares Outstanding history
YEARShares OutstandingYoY
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M0.00%
3.60 M+327.27 M%
1.100.00%
1.100.00%
1.100.00%
1.100.00%
1.100.00%
1.100.00%
1.100.00%
1.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioethics Number of shares

Bioethics shares outstanding

The number of shares of Bioethics was 1.49 M in 2025. This indicates how many shares Bioethics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
1.10 M Stocks
Jan 1, 2019
1.10 M Stocks
Jan 1, 2020
1.14 M Stocks
Jan 1, 2021
1.14 M Stocks
Jan 1, 2022
1.14 M Stocks
Jan 1, 2023
1.14 M Stocks
Jan 1, 2024
3.34 M Stocks
Jan 1, 2025
1.49 M Stocks

Bioethics Stock analysis

What does Bioethics do? Bioethics Ltd. is a shell company with no operations or revenue. The company has no full-time employees and is formed to pursue a merger, share exchange, asset acquisition, or similar business combination with another entity. It has not identified any specific target for such a transaction and has not engaged in any substantive discussions with potential partners. The firm remains inactive without generating any income from operations. Bioethics Ltd. does not sell any products or services. It is structured as a vehicle for future business combinations, with no current business activities or revenue streams. The company's purpose is limited to seeking a merger or acquisition target, and it has not yet entered into any agreements or initiated any operational activities. There are no brands, customers, or segments associated with its current status. The firm is headquartered in Ogden, Utah, but this location is not used for any operational purposes. Bioethics Ltd. has no employees, no revenue, and no business activities beyond the formation of the shell company itself. It has not generated any income or engaged in any transactions that would produce revenue. Bioethics is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Bioethics's Shares Outstanding

Bioethics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Bioethics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Bioethics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Bioethics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Bioethics stock

The number of shares of Bioethics is 3.60 M in 2025.

The number of shares of Bioethics changed from 3.60 M to 3.60 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Bioethics since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Bioethics

All Key Metrics — Bioethics